CN110294775A - 一种磷酸肌酸钠的纯化方法 - Google Patents
一种磷酸肌酸钠的纯化方法 Download PDFInfo
- Publication number
- CN110294775A CN110294775A CN201810244057.4A CN201810244057A CN110294775A CN 110294775 A CN110294775 A CN 110294775A CN 201810244057 A CN201810244057 A CN 201810244057A CN 110294775 A CN110294775 A CN 110294775A
- Authority
- CN
- China
- Prior art keywords
- phosphate sodium
- creatine phosphate
- creatine
- liquid
- purification process
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- DRBBFCLWYRJSJZ-UHFFFAOYSA-N N-phosphocreatine Chemical compound OC(=O)CN(C)C(=N)NP(O)(O)=O DRBBFCLWYRJSJZ-UHFFFAOYSA-N 0.000 title claims abstract description 193
- 239000011734 sodium Substances 0.000 title claims abstract description 98
- 229910052708 sodium Inorganic materials 0.000 title claims abstract description 98
- 238000000746 purification Methods 0.000 title claims abstract description 29
- 239000007788 liquid Substances 0.000 claims abstract description 65
- 238000006243 chemical reaction Methods 0.000 claims abstract description 58
- 238000010828 elution Methods 0.000 claims abstract description 36
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims abstract description 31
- 238000000034 method Methods 0.000 claims abstract description 30
- 102000004190 Enzymes Human genes 0.000 claims abstract description 21
- 108090000790 Enzymes Proteins 0.000 claims abstract description 21
- 239000006228 supernatant Substances 0.000 claims abstract description 20
- 230000008569 process Effects 0.000 claims abstract description 19
- 238000001728 nano-filtration Methods 0.000 claims abstract description 18
- 230000001376 precipitating effect Effects 0.000 claims abstract description 15
- 238000001035 drying Methods 0.000 claims abstract description 9
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000012610 weak anion exchange resin Substances 0.000 claims abstract description 8
- 239000003729 cation exchange resin Substances 0.000 claims abstract description 7
- 239000000047 product Substances 0.000 claims abstract description 7
- 239000012609 strong anion exchange resin Substances 0.000 claims abstract description 7
- 238000010521 absorption reaction Methods 0.000 claims abstract description 6
- 239000003480 eluent Substances 0.000 claims abstract description 4
- 238000012869 ethanol precipitation Methods 0.000 claims abstract description 4
- 238000011068 loading method Methods 0.000 claims description 55
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 claims description 43
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 41
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- 235000019441 ethanol Nutrition 0.000 claims description 24
- 239000006046 creatine Substances 0.000 claims description 22
- 229960003624 creatine Drugs 0.000 claims description 22
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 claims description 19
- 239000011780 sodium chloride Substances 0.000 claims description 18
- 229910019142 PO4 Inorganic materials 0.000 claims description 13
- 239000010452 phosphate Substances 0.000 claims description 13
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 claims description 12
- 238000001914 filtration Methods 0.000 claims description 12
- 229910001425 magnesium ion Inorganic materials 0.000 claims description 12
- 238000000108 ultra-filtration Methods 0.000 claims description 12
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 11
- 229910052799 carbon Inorganic materials 0.000 claims description 11
- 239000012535 impurity Substances 0.000 claims description 9
- 239000002158 endotoxin Substances 0.000 claims description 8
- WAEMQWOKJMHJLA-UHFFFAOYSA-N Manganese(2+) Chemical compound [Mn+2] WAEMQWOKJMHJLA-UHFFFAOYSA-N 0.000 claims description 6
- 229910001437 manganese ion Inorganic materials 0.000 claims description 6
- 239000012528 membrane Substances 0.000 claims description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 4
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 4
- 102000004420 Creatine Kinase Human genes 0.000 claims description 4
- 108010042126 Creatine kinase Proteins 0.000 claims description 4
- 229910001424 calcium ion Inorganic materials 0.000 claims description 4
- 230000008929 regeneration Effects 0.000 claims description 4
- 238000011069 regeneration method Methods 0.000 claims description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 3
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 claims description 3
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 claims description 3
- 229920002521 macromolecule Polymers 0.000 claims description 3
- 229910001414 potassium ion Inorganic materials 0.000 claims description 3
- 150000003141 primary amines Chemical group 0.000 claims description 3
- 125000001302 tertiary amino group Chemical group 0.000 claims description 3
- 125000003277 amino group Chemical group 0.000 claims description 2
- PTMHPRAIXMAOOB-UHFFFAOYSA-N phosphoramidic acid Chemical group NP(O)(O)=O PTMHPRAIXMAOOB-UHFFFAOYSA-N 0.000 claims description 2
- 125000000467 secondary amino group Chemical class [H]N([*:1])[*:2] 0.000 claims description 2
- 230000014759 maintenance of location Effects 0.000 claims 1
- 230000003068 static effect Effects 0.000 abstract description 2
- 235000015424 sodium Nutrition 0.000 description 73
- 239000000243 solution Substances 0.000 description 49
- 239000011347 resin Substances 0.000 description 31
- 229920005989 resin Polymers 0.000 description 31
- 238000005342 ion exchange Methods 0.000 description 17
- 239000000843 powder Substances 0.000 description 16
- 238000012360 testing method Methods 0.000 description 16
- 239000013078 crystal Substances 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 12
- XTWYTFMLZFPYCI-KQYNXXCUSA-K ADP(3-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-K 0.000 description 11
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 11
- 235000011121 sodium hydroxide Nutrition 0.000 description 10
- 238000004128 high performance liquid chromatography Methods 0.000 description 9
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 8
- 238000001179 sorption measurement Methods 0.000 description 8
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000012530 fluid Substances 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 239000012141 concentrate Substances 0.000 description 6
- RNTXMYSPASRLFT-UHFFFAOYSA-L disodium;2-[[n'-[hydroxy(oxido)phosphoryl]carbamimidoyl]-methylamino]acetate Chemical compound [Na+].[Na+].OC(=O)CN(C)C(N)=NP([O-])([O-])=O RNTXMYSPASRLFT-UHFFFAOYSA-L 0.000 description 6
- 150000002500 ions Chemical class 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000003912 environmental pollution Methods 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- 238000001696 ion exchange chromatographie Methods 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 159000000003 magnesium salts Chemical class 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229950007002 phosphocreatine Drugs 0.000 description 2
- 239000012465 retentate Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000010189 synthetic method Methods 0.000 description 2
- VDZOOKBUILJEDG-UHFFFAOYSA-M tetrabutylammonium hydroxide Chemical compound [OH-].CCCC[N+](CCCC)(CCCC)CCCC VDZOOKBUILJEDG-UHFFFAOYSA-M 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 229910021380 Manganese Chloride Inorganic materials 0.000 description 1
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-L Phosphate ion(2-) Chemical compound OP([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-L 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- QOBLJVUECBDJGF-UHFFFAOYSA-N [Mg].CC(O)=O Chemical compound [Mg].CC(O)=O QOBLJVUECBDJGF-UHFFFAOYSA-N 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000003957 anion exchange resin Substances 0.000 description 1
- 150000001449 anionic compounds Chemical class 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229910001422 barium ion Inorganic materials 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000004134 energy conservation Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 229910001412 inorganic anion Inorganic materials 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 235000002867 manganese chloride Nutrition 0.000 description 1
- 239000011565 manganese chloride Substances 0.000 description 1
- 229940099607 manganese chloride Drugs 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- -1 phosphate compound Chemical class 0.000 description 1
- 125000005499 phosphonyl group Chemical group 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002633 protecting effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 159000000000 sodium salts Chemical group 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- NIAGBSSWEZDNMT-UHFFFAOYSA-M tetraoxidosulfate(.1-) Chemical compound [O]S([O-])(=O)=O NIAGBSSWEZDNMT-UHFFFAOYSA-M 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/22—Amides of acids of phosphorus
- C07F9/222—Amides of phosphoric acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810244057.4A CN110294775B (zh) | 2018-03-23 | 2018-03-23 | 一种磷酸肌酸钠的纯化方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810244057.4A CN110294775B (zh) | 2018-03-23 | 2018-03-23 | 一种磷酸肌酸钠的纯化方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110294775A true CN110294775A (zh) | 2019-10-01 |
CN110294775B CN110294775B (zh) | 2021-11-26 |
Family
ID=68025694
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810244057.4A Active CN110294775B (zh) | 2018-03-23 | 2018-03-23 | 一种磷酸肌酸钠的纯化方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110294775B (zh) |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101033237A (zh) * | 2007-03-30 | 2007-09-12 | 上海华拓医药科技发展股份有限公司 | 药用磷酸肌酸二钠盐六水合物及其制备方法 |
WO2007146085A2 (en) * | 2006-06-06 | 2007-12-21 | Xenoport, Inc. | Creatine phosphate prodrugs, compositions and uses thereof |
CN101492470A (zh) * | 2008-01-22 | 2009-07-29 | 上海慈瑞医药科技有限公司 | 磷酸肌酸二钠盐的合成方法 |
CN101812088A (zh) * | 2010-03-19 | 2010-08-25 | 海南美大制药有限公司 | 一种高纯度的磷酸肌酸钠化合物 |
CN102295658A (zh) * | 2011-06-02 | 2011-12-28 | 重庆莱美药业股份有限公司 | 一种磷酸肌酸二钠盐的精制方法 |
CN103014083A (zh) * | 2012-12-31 | 2013-04-03 | 湖南宝利士生物技术有限公司 | 一种磷酸肌酸钠的制备方法 |
CN103012472A (zh) * | 2012-12-10 | 2013-04-03 | 天津大学 | 一种磷酸肌酸钠的结晶制备方法 |
CN103242364A (zh) * | 2012-12-28 | 2013-08-14 | 开封明仁药业有限公司 | 磷酸肌酸钠的制备方法 |
CN105132489A (zh) * | 2015-10-16 | 2015-12-09 | 西南药业股份有限公司 | 磷酸肌酸钠的制备方法 |
CN105153222A (zh) * | 2015-10-16 | 2015-12-16 | 西南药业股份有限公司 | 磷酸肌酸钠的纯化方法 |
CN106279267A (zh) * | 2015-05-20 | 2017-01-04 | 重庆圣华曦药业股份有限公司 | 一种磷酸肌酸钠的纯化方法及其无菌粉的制备 |
CN106928288A (zh) * | 2017-03-21 | 2017-07-07 | 华北制药华胜有限公司 | 一种硫酸双氢链霉素的制备方法 |
-
2018
- 2018-03-23 CN CN201810244057.4A patent/CN110294775B/zh active Active
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007146085A2 (en) * | 2006-06-06 | 2007-12-21 | Xenoport, Inc. | Creatine phosphate prodrugs, compositions and uses thereof |
CN101033237A (zh) * | 2007-03-30 | 2007-09-12 | 上海华拓医药科技发展股份有限公司 | 药用磷酸肌酸二钠盐六水合物及其制备方法 |
CN101492470A (zh) * | 2008-01-22 | 2009-07-29 | 上海慈瑞医药科技有限公司 | 磷酸肌酸二钠盐的合成方法 |
CN101812088A (zh) * | 2010-03-19 | 2010-08-25 | 海南美大制药有限公司 | 一种高纯度的磷酸肌酸钠化合物 |
CN102295658A (zh) * | 2011-06-02 | 2011-12-28 | 重庆莱美药业股份有限公司 | 一种磷酸肌酸二钠盐的精制方法 |
CN103012472A (zh) * | 2012-12-10 | 2013-04-03 | 天津大学 | 一种磷酸肌酸钠的结晶制备方法 |
CN103242364A (zh) * | 2012-12-28 | 2013-08-14 | 开封明仁药业有限公司 | 磷酸肌酸钠的制备方法 |
CN103014083A (zh) * | 2012-12-31 | 2013-04-03 | 湖南宝利士生物技术有限公司 | 一种磷酸肌酸钠的制备方法 |
CN106279267A (zh) * | 2015-05-20 | 2017-01-04 | 重庆圣华曦药业股份有限公司 | 一种磷酸肌酸钠的纯化方法及其无菌粉的制备 |
CN105132489A (zh) * | 2015-10-16 | 2015-12-09 | 西南药业股份有限公司 | 磷酸肌酸钠的制备方法 |
CN105153222A (zh) * | 2015-10-16 | 2015-12-16 | 西南药业股份有限公司 | 磷酸肌酸钠的纯化方法 |
CN106928288A (zh) * | 2017-03-21 | 2017-07-07 | 华北制药华胜有限公司 | 一种硫酸双氢链霉素的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN110294775B (zh) | 2021-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105669560A (zh) | 一种从发酵液中分离提取四氢嘧啶的方法 | |
CN104529755B (zh) | 一种从转化液中分离α-酮戊二酸的方法 | |
CN108358989A (zh) | 一种从微生物发酵液中分离纯化胞苷的方法 | |
CN102875669B (zh) | 卵转铁蛋白的分离提取的方法 | |
CN108276292A (zh) | 一种1,5-戊二胺的分离方法 | |
KR900009054B1 (ko) | 설포-아데노실-l-메티오닌염의 제조방법 | |
CN109678743B (zh) | 一种l-缬氨酸的分离纯化方法 | |
CN110759959B (zh) | 一种从发酵液中分离提取维生素b12的方法 | |
CN110294775A (zh) | 一种磷酸肌酸钠的纯化方法 | |
CN106496077B (zh) | 一种从樟脑磺酸合成母液回收樟脑磺酸的方法 | |
CN112266362A (zh) | 一种双水相萃取结合离子交换层析提取四氢嘧啶的方法 | |
CN101805382A (zh) | 一种高纯度奈替米星的分离纯化方法 | |
CN105566445B (zh) | 一种分离纯化还原型谷胱甘肽的方法 | |
CN106279197A (zh) | 异山梨醇反应溶液的纯化及结晶工艺 | |
CN104119241A (zh) | 一种l-亮氨酸的提取方法 | |
CN108997154B (zh) | 具有低氯化钠含量和低吸湿性的甜菜碱制剂制备方法 | |
CN105418461A (zh) | 一种l-精氨酸的连续离子交换提取工艺 | |
CN109851520A (zh) | 一种l-茶氨酸的分离纯化方法 | |
CN108752224B (zh) | 一种醋酸赖氨酸原料药的制备方法 | |
CN101073666B (zh) | 一种制备胰激肽原酶原料药的方法 | |
CN107827803A (zh) | 一种从发酵液中提取l‑羟脯氨酸的方法 | |
CN107827977A (zh) | 一种基于离子交换树脂纯化乌司他丁的方法 | |
CN101991601B (zh) | 一种尿多酸肽组合物的制备方法 | |
CN101085749A (zh) | 一种土霉素的分离方法 | |
CN113563397B (zh) | 阿贝卡星的纯化方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A Purification Method for Sodium Phosphate Creatine Effective date of registration: 20230509 Granted publication date: 20211126 Pledgee: Anqing rural commercial bank Limited by Share Ltd. Pledgor: Anhui Gute Biotechnology Co.,Ltd. Registration number: Y2023980040047 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20211126 Pledgee: Anqing rural commercial bank Limited by Share Ltd. Pledgor: Anhui Gute Biotechnology Co.,Ltd. Registration number: Y2023980040047 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |